Stem Cell Factor as a Survival and Growth Factor in Human Normal and Malignant Hematopoiesis

Acta Haematologica

Volumn 95, Issue 3-4, 1996, Pages 257-262

  Hassan, H T ^a   Zander, A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Hematopoiesis; Leukemia; Megakaryocytopoiesis; Stem cell factor

Indexed keywords

ANTIINFECTIVE AGENT; CARBOPLATIN; CD34 ANTIGEN; CYTARABINE; CYTOKINE; DAUNORUBICIN; GROWTH FACTOR; HERMES ANTIGEN; INTERLEUKIN 4; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; BLAST CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESISTANCE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; STEM CELL;

ACUTE DISEASE; APOPTOSIS; CELL SURVIVAL; CYTOKINES; GROWTH SUBSTANCES; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR;

EID: 0030048429     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203893     Document Type: Article

References (50)

1. Geissler EN, Liao M, Brook JD, Martin FH, Zsebo KM, Housman DE, Galli SJ: Stem cell factor, a novel hematopoietic growth factor and ligand for c-Kit tyrosine kinase receptor, maps on human chromosome 12 between 12ql4.3 and 12qtcr. Somat Cell Mol Genetic 1991; 17: 207-214.
2. Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK: c-kitis expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 1994;22:157-165.
3. Qui F, Ray P, Brown K, Barker PE, Jhawer S, Ruddle FH, Besmer P: Primary structure of c-Kit. Relationship with theCSF-l/PDGF receptor kinase family: Oncogenic activation of c-Kit involves deletion of extracellular domain and C-terminus. EMBO J 1988;7:1003-1011.
4. Lyman SD, James L, Vandenbos T, Den ies P, Brasel K, Kliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR: Molecular cloning of a ligand for the Flt3/Flk2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 1993;75:1157—1167.
5. Small D, Levenstein M, Kim E, Carow CE, Amin S, Rockwell P, Witte L, Burrow C, Ra-tajczak M, Gewirtz AM, Civin CI: STK-1, the human homolog of Flk2/Flt3 is selectively expressed in CD34+ human bone marrow' cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994;91:459-463.
6. Langley KE, Bennet LG, Wypych J, Yancik SA, Liu XD, Westcott KR, Chang DG, Smith KA, Zsebo KM: Soluble stem cell factor in human serum. Blood 1993;81:656-660.
7. Bowen D, Yancik S, Bennett L, Culligan D, Rcsscr K: Serum stem cell factor concentration in patients with myelodysplastic syndromes. Br J Haematol 1993;85:63-66.
8. Wodnar-Filipowicz A, Yancik S, Moser Y, Dalle-Carbonare V, Gratwohl A, Tichelli A, Speck B, Nisscn C: Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood 1993;81:3259-3264.
9. Wunder E, Mortensen BT, Schilling F, Henon PR: Anomalous plasma concentrations and impaired secretion of growth factors in Fanconi’s anemia. Stem Cells (Dayt) 1993; 11 (suppl 2): 144-149.
10. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 1991; 19:226—231.
11. Carow CE, Hangoc G, Cooper SH, Williams DE, Broxmeyer HE: Mast cell growth factor (c-Kit ligand) supports the growth of human multipotential progenitor cells with a high repopulating potential. Blood 1991;78:2216-2221.
12. Bernstein ID, Andrews RG, Zsebo KM: Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells and the generation of colony-forming cell progeny from CD34+lin- cells cultured with IL-3. G-CSF or GM-CSF. Blood 1991;77:2316-2321.
13. Firkin F, Dunlop J, Bertoncello I: Expansion of hemopoietic activity in long-term culture of human bone marrow by c-Kit ligand (stem cell factor). Grow th Factors 1993;8:135-140.
14. Liesveld JL, Broudy VC, Harbol AW, Abboud CN: Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems. Exp Hematol 1995;23:202-209.
15. Sekhsaria S, Malech HL: Recombinant human stem cell factor enhances myeloid colony growth from human peripheral blood progenitors. Blood 1993;81:2125-2130.
16. Gabutti V, Timeus F, Ramenghi U, Crescenzio N, Marranca D, Miniero R, Cornaglia G, Bag-nara GP: Expansion of cord blood progenitors and use for hemopoietic reconstitution. Stem Cells (Dayt) 1993; 11 (suppl 2): 105-112.
17. Kobayashi H: Effcct of c-Kit ligand (stem ccll factor) in combination with IL-5, GM-CSF and IL-3 on eosinophil lineage. Int J Hematol 1993; 58:21-26.
18. Briddel RA, Bruno E, Cooper RJ, Brandt JE, Hoffman R: Effect of c-Kit ligand on in vitro human megakaryocvtopoiesis. Blood 1991;78: 2854-2859.
19. Avraham H, Vannier E, Cowley S, Jiang SX, Chi S, Dinarello CA, Zsebo KM. Groopman JE: Effects of stem cell factor, c-Kit ligand, on human megakaryocytic cells. Blood 1992;79: 365-371.
20. Imai T, Nakahata T: Stem cell factor promotes proliferation of human primitive megakaryocytic progenitors, but not megakaryocytic maturation. Int J Hematol 1994;59:91-98.
21. McNiece IK, Langley KE, Zsebo KM: The role of recombinant stem cell factor in early B cell development: Synergistic interaction with IL-7. J Immunol 1991:146:3785-3790.
22. Wincman JP, Nishikawa SI, Miiller-Sieburg CE: Maintenance of high levels of pluripotent hematopoietic stem cells in vitro: Effect of stromal cells and c-Kit ligand. Blood 1993;81:365— 372.
23. Muta K, Krantz SB: Apoptosis of human ery-throid colony forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Ccll Physiol 1993; 156:264-271.
24. Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R: In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 1993; 82:784-791.
25. Soligo D, Servida F, Cortelezzi A, Pedretti D, Uziel L, Morgutti M, Pogliani E, Lambcr-tenghi-Deliliers G: Effects of recombinant human stem cell factor on colony formation and long-term bone marrow cultures in patients with myelodysplastic syndromes. Eur J Haematol 1994;52:53-60.
26. Amano Y, Koike K, Nakahata T: Stem cell factor enhances the growth of primitive crythroid progenitors to a greater extent than IL-3 in patients with aplastic anemia. Br J Haematol 1983;85:663-669.
27. Bacigalupo A, Piaggio G, Podesta M, Raffo MR, Tedone E, Sogno G, Benvenuto F, Figari O, Grassia L, Bagnara GP: In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia. Stem Cells (Dayt) 1993; 11 (suppl 2): 175-179.
28. Bagnara GP, Strippoli P, Bonsi L, Brizzi MF, Avanzi GC, Timeus F, Ramenghi U, Piaggio G, Tong J, Podesta M: Effcct of stem ccll factor on colony growth from acquired and constitutional Fanconi’s anemia. Blood 1992;80:382— 387.
29. Abkowitz JL, Sabo KM, Nakamoto B, Blau CA, Martin FH, Zsebo KM, Papayannopoulou T: Diamond-Blackfan anemia: In vitro response of erythroid progenitors to the ligand for c-Kit. Blood 1991;78:2198-2202.
30. Alter BP, Knobloch ME, He L, Gillio AP, O'Reilly RJ, Reilly LK, Weinberg RS: Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes. Blood 1992;80:3000-3009.
31. Nara N, Tanikawa S, Nagta K, Hamaguchi H, Tomiyama J: Effccts of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia. Int J Hematol 1993;58:27-35.
32. Ikeda H, Kanakura Y, Furitsu T, Kitayama H, Sugahara H, Nishiura T, Karasuno T, Tomiyama Y, Yamatodani A, Kanayama Y: Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor. Exp Hematol 1993; 21:1686-1694.
33. Strife A, Perez A, Lambek C, Wisniewiski D, Bruno S, Darzynkiewicz Z, Clarkson B: Characterisation of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-Kit ligand. Cancer Res 1993;53:401-409.
34. Brach MA, Buhring HJ, Gruss HJ: Functional expression of c-kitby AML blasts is enhanced by TNF-alpha through posttranscriptional mRNA stabilisation by a labile protein. Blood 1992:80:1224-1230.
35. Siitonen T, Savolainen ER, Koistinen O: Expression of the c-kitproto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia 1994;8:631-636.
36. Hu ZB, Ma W, Uphoff CC, Quentmeier H, Drexler HG: c-kitexpression in human mega-karyoblastic leukemia ccll lines. Blood 1994; 83:2133-2144.
37. de Vos S, Brach MA, Asano Y: TGF-beta interferes with the proliferation inducing activity of stem cell factor in myelogenous leukemia blasts through down regulation of the c-kitprotooncogene product. Cancer Res 1993;53:3638— 3642.
38. Asano Y, Brach MA, Ahlers A: Phorbol ester (TPA) down regulates expression of the c-kitproto-oncogene product. J Immunol 1993:151: 2345-2354.
39. Oez S, Birkmann J, Smetak M, Corbacioglu S, Hofmann-Wackersreuther G, Welte K. Gall-meier WM: Regulation of the density of the stem cell factor receptor (c-Kit) by tumor nc-crosis factor alpha on a human myeloid cell line. Eur Cytokine Nctw 1993;4:439-445.
40. Green DR, Bissonnettee RP, Cotter TG: Apoptosis and cancer; in De Vita VT, Heilman S, Rosenberg SA (eds): Important Advances in Oncology 1994. Philadelphia, Lippincott, 1994;37-52.
41. Parachaidou A, Saikia T, Locw J: Assessment of apoptosis in serial bone marrow biopsies of 53 patients with newly diagnosed high risk AML following induction therapy (abstract 312). Blood 1994:84:1234.
42. Sachs L, Lotcm J: Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 1993;82:15-21.
43. Pietsch T, Kyas U, Ludwig WD, Welte K: Mitogenic effect of human stem cell factor alone and in combination with G-CSF, GM-CSF, and IL-3 on fresh lcukcmic blast cells from patients with stem ccll factor receptor-positive AML: in Freund M, Link H, Schmidt M, Welte K (eds): Cytokines in Hemopoiesis, Oncology and Aids II. Berlin. Springer, 1992, pp 171-178.
44. Molineux D, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM: The effect of hemato-poiesis of recombinant stem cell factor (ligand for c-Kit) administered in vivo to mice either alone or in combination with G-CSF. Blood 1991;78:961-966.
45. Briddcll RA, Hartley C, Stoney G, McNiece I: SCF synergises with G-CSF in vivo to mobilise murine peripheral blood progenitor cells with enhanced engraftment potential. Exp Hematol 1993,21:1150-1158.
46. Andrews RG, Briddcll RA, Kintter GH, Rowley SD, Appelbaum FR, McNiece I: Rapid engraftment by peripheral blood progenitor cells mobilised by recombinant human SCF and rccombinant human G-CSF in nonhuman primates. Blood 1995;85:15-21.
47. Drize NJ, Chertkov JL, Zander AR: Hematopoietic stem cell mobilisation into peripheral blood of mice by combination of recombinant rat SCF and recombinant human G-CSF. Exp Hematol 1995;23:1179-1185.
48. Yan XQ, Hartley C, McElroy T, McNiece I: Serial transplantation of SCF plus G-CSF mobilised PBPC demonstrated long term engraftment in secondary recipient mice (abstract 344). Blood 1994;84(suppl 1):1361.
49. Andrews RG, Briddell RA, Appelbaum FR, McNiece IK: Stimulation of hematopoiesis in vivo by stem cell factor. Curr Hematol 1994; I: 187-195.
50. Begley CG, Basscr R, Mansfield R, Maher D, To B, Juttner C, Fox R. Cebon J, Grigg A, Szer J, McGrath K, Thomson B, Sheridan W, Men-chaca D, Collins J, Russell I. Green M: Randomised prospective study demonstrating a prolcnged effect of SCF with G-CSF on PBPC in untreated cancer patients: Early results (abstract 25). Blood 1994;84(suppl 1):90.